Citius Oncology, Inc. CTOR Related Transaction Costs
Related Transaction Costs at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:RelatedTransactionCosts.
The official record: Citius Oncology, Inc.’s 10-Q, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s related transaction costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s related transaction costs?
- Citius Oncology, Inc. (CTOR) reported related transaction costs of $2.36M in Q4 2025.
- How has Citius Oncology, Inc.'s related transaction costs changed year-over-year?
- Citius Oncology, Inc.'s related transaction costs increased by 300.0% year-over-year, from $589.7K to $2.36M.
- What does related transaction costs mean?
- Encompasses incidental expenses directly attributable to specific corporate transactions, such as legal, advisory, or consulting fees. Tracking these costs helps assess the overhead burden associated with executing strategic corporate initiatives.